CSTL

16.80

2.94% 0.48

Dopo l'orario di chiusura: 16.75 -0.05 -0.30%

Castle Biosciences Inc (CSTL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché CSTL Giù? Forum Previsione

Precedente Chiudi:

$16.32

Aprire:

$17.075

Volume 24 ore:

164.69K

Relative Volume:

0.36

Capitalizzazione di mercato:

$485.05M

Reddito:

$219.79M

Utile/perdita netta:

$-57.47M

Rapporto P/E:

-7.814

EPS:

-2.15

Flusso di cassa netto:

$-19.25M

1 W Prestazione:

-10.06%

1M Prestazione:

-10.88%

6M Prestazione:

-36.60%

1 anno Prestazione:

-17.20%

Intervallo 1D:

$16.77

$17.25

Intervallo di 1 settimana:

$16.16

$18.91

Portata 52W:

$15.45

$35.84

Castle Biosciences Inc Stock (CSTL) Company Profile

Nome

Castle Biosciences Inc

Settore

Healthcare (1163)

Industria

Diagnostics & Research (55)

Telefono

866-788-9007

Indirizzo

505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX

Dipendente

784

Cinguettio

@castlebio

Prossima data di guadagno

2024-11-04

Ultimi documenti SEC

CSTL's Discussions on Twitter

Confronta CSTL con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CSTL Castle Biosciences Inc	16.80	471.20M	219.79M	-57.47M	-19.25M	-2.15
TMO Thermo Fisher Scientific Inc	466.71	161.42B	42.90B	6.52B	6.72B	17.05
DHR Danaher Corp	197.89	135.99B	24.01B	3.41B	4.86B	4.70
IDXX Idexx Laboratories Inc	540.68	42.78B	3.93B	894.97M	837.70M	10.82
A Agilent Technologies Inc	119.47	33.01B	6.63B	1.17B	1.19B	4.05
IQV Iqvia Holdings Inc	194.24	31.85B	15.50B	1.33B	2.16B	7.34

Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-12-14	Iniziato	Guggenheim	Buy
2023-01-05	Iniziato	Scotiabank	Sector Outperform
2022-01-07	Iniziato	Stephens	Overweight
2021-04-30	Iniziato	Lake Street	Buy
2020-11-10	Iniziato	KeyBanc Capital Markets	Overweight
2019-12-27	Reiterato	Canaccord Genuity	Buy
2019-08-19	Iniziato	BTIG Research	Buy
2019-08-19	Iniziato	Canaccord Genuity	Buy
2019-08-19	Iniziato	Robert W. Baird	Outperform
2019-08-19	Iniziato	SVB Leerink	Outperform

Mostra tutto

Castle Biosciences Inc Borsa (CSTL) Ultime notizie

Jul 23, 2025

What analysts say about Castle Biosciences Inc. stockSkyrocketing investment returns - Autocar Professional

Jul 23, 2025

What drives Castle Biosciences Inc. stock priceFree Trading Strategy Suggestions - Autocar Professional

Jul 23, 2025

Castle Biosciences stock jumps after FDA grants Breakthrough Device status to melanoma test - MSN

Jul 23, 2025

Castle Bio, Revolution Medicines get FDA breakthrough statuses - Seeking Alpha

Jul 23, 2025

Castle Biosciences stock jumps after FDA grants Breakthrough Device status - Investing.com India

Jul 23, 2025

FDA Grants Breakthrough Status to Melanoma Test - Conexiant

Jul 23, 2025

FDA grants breakthrough device status to Castle Biosciences’ melanoma test - Investing.com Australia

Jul 23, 2025

FDA Grants Breakthrough Device Designation to Castle Biosciences’ DecisionDx®-Melanoma Test - GlobeNewswire

Jul 23, 2025

FDA Grants Breakthrough Device Designation to Castle Biosciences’ DecisionDx®-Melanoma Test - GlobeNewswire Inc.

Jul 23, 2025

New York State Common Retirement Fund Has $3.27 Million Stock Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jul 23, 2025

Jul 22, 2025

Is Castle Biosciences Inc. a good long term investmentHigh-margin investment plays - jammulinksnews.com

Jul 22, 2025

Castle Biosciences Inc. Stock Analysis and ForecastTremendous financial leverage - jammulinksnews.com

Jul 22, 2025

Jul 21, 2025

Teacher Retirement System of Texas Grows Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jul 21, 2025

Stephens Inc. AR Has $273,000 Stake in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jul 21, 2025

Jul 17, 2025

Castle Biosciences Achieves Multiple Awards Recognizing Workplace Excellence in 2025 Top Workplaces Program - Quiver Quantitative

Jul 17, 2025

Castle Biosciences earns multiple Top Workplaces awards, including national Healthcare Industry award. - AInvest

Jul 17, 2025

Castle Biosciences Honored with Multiple Top Workplaces Awards Recognizing the Company’s Strong Culture - GlobeNewswire

Jul 17, 2025

Castle Biosciences Dominates Healthcare Workplace Rankings with 7 Major Awards and #3 Industry Position - Stock Titan

Jul 17, 2025

Jul 16, 2025

How Castle Biosciences Inc. stock performs during market volatilityTop Rated Trade Entries - Newser

Jul 16, 2025

Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jul 16, 2025

Castle Biosciences to Release Q2 2025 Financial Results and Host Conference Call on Aug. 4 - AInvest

Jul 16, 2025

Jul 15, 2025

Why Castle Biosciences Inc. stock attracts strong analyst attentionEarly Buy Suggestion - Newser

Jul 15, 2025

What makes Castle Biosciences Inc. stock price move sharplyProven Trading Plan - Newser

Jul 15, 2025

Jul 14, 2025

Castle Biosciences' Q2 Results: Diagnostic Innovation Fuels Growth Amid Profit Challenges - AInvest

Jul 14, 2025

Castle Biosciences, Inc. to Release Second Quarter Financial Results on August 4, 2025 - Nasdaq

Jul 14, 2025

Castle Biosciences to Release Second Quarter 2025 Financial - GlobeNewswire

Jul 14, 2025

Castle Biosciences Sets Q2 2025 Earnings Date: Key Financial Results Coming August 4 - Stock Titan

Jul 14, 2025

Jul 07, 2025

Allspring Global Investments Holdings LLC Raises Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jul 07, 2025

Jun 30, 2025

Castle Biosciences, Inc.(NasdaqGM: CSTL) dropped from Russell 2500 Growth Index - MarketScreener

Jun 30, 2025

Jun 28, 2025

Is Castle Biosciences (NASDAQ:CSTL) Using Too Much Debt? - 富途牛牛

Jun 28, 2025

Jun 25, 2025

GAMMA Investing LLC Purchases 4,142 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jun 25, 2025

Castle Biosciences partners with SciBase for diagnostic tests - MSN

Jun 25, 2025

Jun 19, 2025

Castle Biosciences Awards Major RSU Package: 135,978 Shares with 4-Year Vesting for Employee Retention - Stock Titan

Jun 19, 2025

Jun 17, 2025